Correction to: Randomized controlled trial of sulforaphane and metabolite discovery in children with Autism Spectrum Disorder

• Andrew W. Zimmerman,
• Kanwaljit Singh,
• Susan L. Connors,
• Hua Liu,
• Anita A. Panjwani,
• Li‑Ching Lee,
• Eileen Diggins,
• Ann Foley,
• Stepan Melnyk,
• Indrapal N. Singh,
• S. Jill James,
• Richard E. Frye,
• Jed W. Fahey

Affiliations

Andrew W. Zimmerman

Departments of Pediatrics, Neurology and Psychiatry, University of Massachusetts Medical School

Kanwaljit Singh

Departments of Pediatrics, Neurology and Psychiatry, University of Massachusetts Medical School

Susan L. Connors

Departments of Pediatrics, Neurology and Psychiatry, University of Massachusetts Medical School

Hua Liu

Department of Pharmacology and Molecular Sciences, and The Cullman Chemoprotection Center, Johns Hopkins University School of Medicine

Anita A. Panjwani

Department of Psychiatry and Behavioral Sciences, and iMIND Hopkins, Johns Hopkins University School of Medicine

Li‑Ching Lee

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health

Eileen Diggins

Departments of Pediatrics, Neurology and Psychiatry, University of Massachusetts Medical School

Ann Foley

Departments of Pediatrics, Neurology and Psychiatry, University of Massachusetts Medical School

Stepan Melnyk

Department of Pediatrics, University of Arkansas for Medical Sciences

Indrapal N. Singh

Barrow Neurologic Institute at Phoenix Children’s Hospital and Department of Child Health, University of Arizona College of Medicine – Phoenix

S. Jill James

Department of Pediatrics, University of Arkansas for Medical Sciences

Richard E. Frye

Barrow Neurologic Institute at Phoenix Children’s Hospital and Department of Child Health, University of Arizona College of Medicine – Phoenix

Jed W. Fahey

Department of Pharmacology and Molecular Sciences, and The Cullman Chemoprotection Center, Johns Hopkins University School of Medicine